Tartronic Acid as a Potential Inhibitor of Pathological Calcium Oxalate Crystallization.

Autor: Su Y; Department of Pharmaceutics, China Pharmaceutical University, Nanjing, 211198, China.; Department of Pharmaceutical Engineering, China Pharmaceutical University, Nanjing, 211198, China., Li S; Department of Chemical and Biomolecular Engineering, University of Houston, Houston, TX, 77204, USA., Li X; The State Key Lab of Pharmaceutical Biotechnology, College of Life Science, Nanjing University, Nanjing, 210036, China., Zhou JY; Department of Pharmaceutical Engineering, China Pharmaceutical University, Nanjing, 211198, China., Chauhan VP; Department of Chemical and Biomolecular Engineering, University of Houston, Houston, TX, 77204, USA., Li M; Department of Pharmaceutical Engineering, China Pharmaceutical University, Nanjing, 211198, China., Su YH; Department of Pharmaceutical Engineering, China Pharmaceutical University, Nanjing, 211198, China., Liu CM; Department of Pharmaceutical Engineering, China Pharmaceutical University, Nanjing, 211198, China., Ren YF; Department of Pharmaceutical Engineering, China Pharmaceutical University, Nanjing, 211198, China., Yin W; The State Key Lab of Pharmaceutical Biotechnology, College of Life Science, Nanjing University, Nanjing, 210036, China., Rimer JD; Department of Chemical and Biomolecular Engineering, University of Houston, Houston, TX, 77204, USA., Cai T; Department of Pharmaceutics, China Pharmaceutical University, Nanjing, 211198, China.; Department of Pharmaceutical Engineering, China Pharmaceutical University, Nanjing, 211198, China.
Jazyk: angličtina
Zdroj: Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2024 Jun; Vol. 11 (21), pp. e2400642. Date of Electronic Publication: 2024 Apr 22.
DOI: 10.1002/advs.202400642
Abstrakt: Kidney stones are a pervasive disease with notoriously high recurrence rates that require more effective treatment strategies. Herein, tartronic acid is introduced as an efficient inhibitor of calcium oxalate monohydrate (COM) crystallization, which is the most prevalent constituent of human kidney stones. A combination of in situ experimental techniques and simulations are employed to compare the inhibitory effects of tartronic acid with those of its molecular analogs. Tartronic acid exhibits an affinity for binding to rapidly growing apical surfaces of COM crystals, thus setting it apart from other inhibitors such as citric acid, the current preventative treatment for kidney stones. Bulk crystallization and in situ atomic force microscopy (AFM) measurements confirm the mechanism by which tartronic acid interacts with COM crystal surfaces and inhibits growth. These findings are consistent with in vivo studies that reveal the efficacy of tartronic acid is similar to that of citric acid in mouse models of hyperoxaluria regarding their inhibitory effect on stone formation and alleviating stone-related physical harm. In summary, these findings highlight the potential of tartronic acid as a promising alternative to citric acid for the management of calcium oxalate nephropathies, offering a new option for clinical intervention in cases of kidney stones.
(© 2024 The Authors. Advanced Science published by Wiley‐VCH GmbH.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje